Los puntos clave no están disponibles para este artículo en este momento.
ACT with a nonmyeloablative preparative regimen using either TIL- or TCR gene-transduced cells and interleukin-2 can mediate complete and durable regression of melanoma brain metastases. This strategy can be used safely in selected patients with metastatic melanoma to the brain.
Hong et al. (Thu,) studied this question.